IDH2 and astrocytoma (excluding glioblastoma): Overall, the composition of GBMs nowadays differs greatly from earlier ones in that all IDH-mutant astrocytomas are excluded, and a large number of WHO grade 2-3 IDH-wildtype gliomas with specific molecular features are involved (14).